Cefepime EP Impurity C
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

104301-63-5Cefepime EP Impurity C

● In Stock

Catalogue No.:VE007694
CAS No.:104301-63-5
Mol. Formula:C8H10N4O3S
Mol. Weight:242.26 g/mol

Additional information on CAS 104301-63-5

Parent drug

Cefepime

IUPAC Name

(2Z)-2-(2-Aminothiazol-4-yl)-N-(formylmethyl)-2-(methoxyimino)acetamide

Pharmacopoeial Synonyms

Thiazolyloxime Acetaldehyde (Cefepime Related Compound C)

Other Synonyms

(Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)-N-(2-oxoethyl)acetamide; 4-Thiazoleacetamide, 2-amino-alpha-(methoxyimino)-N-(2-oxoethyl)-, (Z)-

Smiles

CON=C(C1=CSC(=N1)N)C(=O)NCC=O

Inchl

InChI=1S/C8H10N4O3S/c1-15-12-6(7(14)10-2-3-13)5-4-16-8(9)11-5/h3-4H,2H2,1H3,(H2,9,11)(H,10,14)/b12-6-

Shipping Condition

Ambient Temperature

Description

Cefepime EP Impurity C, also known in pharmacopoeias as Thiazolyloxime Acetaldehyde (Cefepime Related Compound C), is a highly characterized reference material. It fully complies with stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for use in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Cefepime. Moreover, it comes with a detailed Structure Elucidation Report (SER), ensuring its accuracy and reliability for a wide range of analytical applications.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url